Dracut, MA, United States of America

Weilun Quan

This inventor holds 23 USPTO granted patents and 4 published patent applications, primarily in Cardiac Defibrillation. Top assignee: Zoll Medical Corporation. Active years: 2014-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Weilun Quan. Retrieved from https://idiyas.com/inventor/weilun-quan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 23 

% Patents Active = 91.3

Average Co-Inventor Count = 2.2

ph-index = 8

Forward Citations = 155(Granted Patents)


Location History:

  • Chelmsford, MA (US) (2014)
  • Dracut, MA (US) (2015 - 2024)

Company Filing History:


Years Active: 2014-2024

Loading Chart...
Areas of Expertise:
Defibrillation
Cardiac Shock
Myocardial Contraction
Spectral Data
Shock Delivery
Energy Selection
Shock Outcome
Rescuer Protection
Transform Value
Shock Success
Vector-Based Indication
Initial Treatments
23 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Weilun Quan - Revolutionizing Cardiac Care

Introduction:

Weilun Quan, a talented inventor based in Dracut, MA, has made significant contributions to the field of medical devices with a remarkable portfolio of 23 patents. His groundbreaking work at Zoll Medical Corporation has revolutionized cardiac care and resuscitation techniques, showcasing his innovative approach to lifesaving technologies.

Latest Patents:

Among Weilun Quan's latest patents is the 'Detection of Myocardial Contractions Indicative of Perfusion,' a sophisticated system designed to assist in cardiopulmonary resuscitation (CPR) treatments. This invention utilizes electrodes and sensors to monitor intrinsic myocardial wall movements, providing crucial real-time feedback to healthcare providers during critical interventions.

Another notable patent is the 'Changing Cardiac Shock Delivery Parameters Based on a Transform Value,' which introduces a novel method for analyzing electrocardiogram (ECG) signals to optimize shock delivery in defibrillation procedures. This innovation highlights Weilun Quan's commitment to enhancing the efficacy and safety of cardiac treatments.

Career Highlights:

Weilun Quan's tenure at Zoll Medical Corporation has been marked by a series of groundbreaking inventions that have redefined standards in medical technology. His keen attention to detail and passion for improving patient outcomes have earned him recognition as a leading innovator in the healthcare industry.

Collaborations:

Throughout his career, Weilun Quan has collaborated closely with esteemed colleagues such as Gary A Freeman and Christopher Luke Kaufman. This spirit of teamwork and shared expertise has been instrumental in driving forward innovative solutions and pushing the boundaries of medical device innovation.

Conclusion:

In conclusion, Weilun Quan's inventive genius and dedication to advancing cardiac care have established him as a trailblazer in the field of medical technology. His patented inventions not only reflect his technical prowess but also exemplify his unwavering commitment to saving lives and improving healthcare practices. We eagerly anticipate Weilun Quan's future contributions and the positive impact they will continue to have on the medical community.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…